Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Postbiotic Bifidobacterium longum CECT 7347 on Gastrointestinal Symptoms, Serum Biochemistry, and Intestinal Microbiota in Healthy Adults: A Randomised, Parallel, Double-Blind, Placebo-Controlled Pilot Study.
Naghibi M, Pont-Beltran A, Lamelas A, Llobregat L, Martinez-Blanch JF, Rojas A, Álvarez B, López Plaza B, Arcos Castellanos L, Chenoll E, Vijayakumar V, Day R. Naghibi M, et al. Nutrients. 2024 Nov 19;16(22):3952. doi: 10.3390/nu16223952. Nutrients. 2024. PMID: 39599737 Free PMC article. Clinical Trial.
An insight into the functional alterations in the gut microbiome of healthy adults in response to a multi-strain probiotic intake: a single arm open label trial.
Rodenes-Gavidia A, Lamelas A, Bloor S, Hobson A, Treadway S, Haworth J, Vijayakumar V, Naghibi M, Day R, Chenoll E. Rodenes-Gavidia A, et al. Among authors: naghibi m. Front Cell Infect Microbiol. 2023 Sep 29;13:1240267. doi: 10.3389/fcimb.2023.1240267. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37841999 Free PMC article. Clinical Trial.
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.
Srivastava S, Basak U, Naghibi M, Vijayakumar V, Parihar R, Patel J, Jadon PS, Pandit A, Dargad RR, Khanna S, Kumar S, Day R. Srivastava S, et al. Among authors: naghibi m. Gut Microbes. 2024 Jan-Dec;16(1):2338322. doi: 10.1080/19490976.2024.2338322. Epub 2024 Apr 17. Gut Microbes. 2024. PMID: 38630015 Free PMC article. Clinical Trial.
Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration.
Jensen BAH, Heyndrickx M, Jonkers D, Mackie A, Millet S, Naghibi M, Pærregaard SI, Pot B, Saulnier D, Sina C, Sterkman LGW, Van den Abbeele P, Venlet NV, Zoetendal EG, Ouwehand AC. Jensen BAH, et al. Among authors: naghibi m. Cell Rep Med. 2023 Sep 19;4(9):101190. doi: 10.1016/j.xcrm.2023.101190. Epub 2023 Sep 7. Cell Rep Med. 2023. PMID: 37683651 Free PMC article. Review.
Nutritional care pathways in cancer patients with malignant bowel obstruction: A retrospective multi-centre study.
Patel PS, Fragkos K, Keane N, Wilkinson D, Johnson A, Chan D, Roberts B, Neild P, Yalcin M, Allan P, FitzPatrick MEB, Gomez M, Williams S, Kok K, Sharkey L, Swift C, Mehta S, Naghibi M, Mountford C, Forbes A, Rahman F, Di Caro S. Patel PS, et al. Among authors: naghibi m. Clin Nutr ESPEN. 2024 Feb;59:118-125. doi: 10.1016/j.clnesp.2023.11.018. Epub 2023 Nov 29. Clin Nutr ESPEN. 2024. PMID: 38220364
76 results